The suitability and tolerability of oats has been a long-standing controversy in the management of coeliac disease (CD). In ...

Diagnosing coeliac disease has long been an arduous and daunting process in which people thought to have the condition have to eat wheat – the very food that will make them sick if the concerns ...

What is coeliac disease - and what can and can’t you eat if you have it? - Just 36 per cent of people with the condition are clinically diagnosed with the condition ...

Patients taking part in a new coeliac disease screening will not have to consume gluten, meaning less pain and a faster diagnosis. AddedJun 10th, 2025 Bystanders aided in the arrest of a man with ...

A Wānaka tradie with no background in fashion has revived a long-lost New Zealand clothing brand from a backyard shed. Nikolai Solakof, a former builder and self-described “marketing nerd ...

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for Kisunla ...

Jeremy Clarkson has criticised the “fun police” Advertising Standards Authority after his high-budget beer advert was banned ...

FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease Provided by PR Newswire Jul 9, 2025, 3:45:00 AM ...

FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease Jul. 09, 2025 6:45 AM ET Eli Lilly and Company (LLY) ...

Kisunla™ (kih-SUHN-lah) is used to treat adults with early symptomatic Alzheimer's disease (AD), which includes mild cognitive impairment (MCI) or mild dementia stage of disease.